These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 30089216

  • 21. Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma.
    Liu W, Liang B, Liu H, Huang Y, Yin X, Zhou F, Yu X, Feng Q, Li E, Zou Z, Wu L.
    Int J Mol Med; 2017 Sep; 40(3):731-738. PubMed ID: 28737823
    [Abstract] [Full Text] [Related]

  • 22. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
    Wang X, Han L, Zhang J, Xia Q.
    Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
    [Abstract] [Full Text] [Related]

  • 23. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
    Hu B, Yan X, Liu F, Zhu C, Zhou H, Chen Y, Liu J, Gu X, Ni R, Zhang T.
    Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway.
    Yu H, Zou D, Ni N, Zhang S, Zhang Q, Yang L.
    J Ovarian Res; 2022 Aug 19; 15(1):98. PubMed ID: 35986371
    [Abstract] [Full Text] [Related]

  • 25. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F.
    Tumour Biol; 2016 Feb 19; 37(2):2497-507. PubMed ID: 26385772
    [Abstract] [Full Text] [Related]

  • 26. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
    Yao Y, Dou C, Lu Z, Zheng X, Liu Q.
    Cell Physiol Biochem; 2015 Feb 19; 35(3):983-96. PubMed ID: 25660117
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX.
    Tumour Biol; 2016 Nov 19; 37(11):15325-15332. PubMed ID: 27704356
    [Abstract] [Full Text] [Related]

  • 28. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q, Wang C, Wang Y, Sun L, Liu Z, Wang L, Song T, Yao Y, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2018 Sep 19; 37(1):231. PubMed ID: 30231922
    [Abstract] [Full Text] [Related]

  • 29. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z, Pan H, Liu S, Zhu J, Qi W, Fu K, Zhao T, Liang J.
    Oncol Rep; 2015 Mar 19; 33(3):1560-6. PubMed ID: 25607597
    [Abstract] [Full Text] [Related]

  • 30. [Effect of TUTF1 expression on the proliferation, apoptosis and prognosis of hepatocellular carcinoma cells].
    Li ZJ, Li JS, Li DY, Pu T.
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov 20; 27(11):879-884. PubMed ID: 31941243
    [Abstract] [Full Text] [Related]

  • 31. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo.
    Kang X, Wang F, Lan X, Li X, Zheng S, Lv Z, Zhuang Y, Zhao Y, Zhou S.
    Int J Med Sci; 2018 Nov 20; 15(1):69-76. PubMed ID: 29333089
    [Abstract] [Full Text] [Related]

  • 32. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
    Li B, Li YM, He WT, Chen H, Zhu HW, Liu T, Zhang JH, Song TN, Zhou YL.
    Oncol Rep; 2016 Jul 20; 36(1):223-30. PubMed ID: 27176873
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
    Wang XP, Yao J, Guan J, Zhou ZQ, Zhang ZY, Yang J.
    Biomed Pharmacother; 2018 Mar 20; 99():817-824. PubMed ID: 29710480
    [Abstract] [Full Text] [Related]

  • 34. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y.
    Biomed Pharmacother; 2018 Nov 20; 107():824-833. PubMed ID: 30142544
    [Abstract] [Full Text] [Related]

  • 35. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
    Liu H, Hu J, Wei R, Zhou L, Pan H, Zhu H, Huang M, Luo J, Xu W.
    J Exp Clin Cancer Res; 2018 Sep 18; 37(1):229. PubMed ID: 30249289
    [Abstract] [Full Text] [Related]

  • 36. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
    He XQ, Zhang YF, Yu JJ, Gan YY, Han NN, Zhang MX, Ge W, Deng JJ, Zheng YF, Xu XM.
    Tumour Biol; 2017 Mar 18; 39(3):1010428317695971. PubMed ID: 28347229
    [Abstract] [Full Text] [Related]

  • 37. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD, Shen F, Ji JS, Zheng K, Huang M, Wu JC.
    Oncol Rep; 2013 Sep 18; 30(3):1275-84. PubMed ID: 23836295
    [Abstract] [Full Text] [Related]

  • 38. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S, Zhang W, Liu K, Ji B, Wang G.
    Mol Med Rep; 2015 Jan 18; 11(1):597-602. PubMed ID: 25323956
    [Abstract] [Full Text] [Related]

  • 39. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC.
    Oncotarget; 2015 Dec 01; 6(38):40920-33. PubMed ID: 26506518
    [Abstract] [Full Text] [Related]

  • 40. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
    Guo ZY, Zhu ZT.
    Eur Rev Med Pharmacol Sci; 2021 Dec 01; 25(23):7238-7251. PubMed ID: 34919223
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.